RWD
R&D/ Views & Analysis/ Views and analysis
COVID-19 vaccine development: Safety monitoring continues revolution in RWD
Catherine Longworth
COVID-19, real world data, RWD, vaccine
0 Comment
R&D/ Views & Analysis/ Views and analysis
The future of real world evidence
mike.hammerton@pharmaphorum.com
BMS, Bristol-Myers Squib, Pfizer, real world data, Real World Evidence, RWD, RWE
0 Comment
R&D/ Views & Analysis/ Views and analysis
Information hubs and the beginning of a data-driven future
Amanda Barrell
IBD Registry, Real word data, Real World Evidence, RWD, RWE
0 Comment
Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
Making real world evidence fit for purpose
George Underwood
clinical trials, HTA, real world data, Real World Evidence, RWD, RWE
0 Comment
Digital/ News/ News/ News/ R&D
AI-powered study backs anticoagulants for heart failure patients without AF
George Underwood
AI, anticoagulant, NOACs, real world data, RWD, Sensyne
0 Comment
R&D/ Views & Analysis/ Views and analysis
Real-world or real evidence?
mike.hammerton@pharmaphorum.com
real word evidence, real world data, RWD, RWE
0 Comment
Oncology/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
Demonstrating the value of RWE
George Underwood
cancer, IQVIA, Real World Evidence, RWD, RWE
0 Comment
Articles/ Cancer/ Digital and Social Media/ Healthcare/ Pharma Market Access/ UK & Europe/ Views and analysis
Is the NHS ready to use real-world evidence to treat cancer?
Linda Banks
cancer, market access, NHS, Oncology, real world data, Real World Evidence, RWD, RWE
0 Comment
Is NHS ready to use real-world data to find new therapies and ways to bring drugs to patients?